tiprankstipranks
Evolent Health sees FY24 revenue $2.55B-$2.575B, consensus $2.58B
The Fly

Evolent Health sees FY24 revenue $2.55B-$2.575B, consensus $2.58B

For the year ending December 31, 2024, revenue is expected to be in the range of approximately $2.55 billion to $2.575 billion and Adjusted EBITDA is expected to be in the range of approximately $160.0 million to $175.0 million.

Pick the best stocks and maximize your portfolio:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App